Innovation
2 patent families (1 granted) — focus: Human necessities; filing pace steady. Cited 156 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Social engagement
Social engagement: 926 social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Orbimed, Shenzhen Capital Group, CS Capital, GP Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 2 | 17% |
| Other / undisclosed | 4 | 33% |
Recent activity
10 Jun 2026
Partnership
Laekna(2105.HK) and Vasque Bio
16 Apr 2026
Partnership
Qilu Pharma
19 Mar 2026
Milestone
revenue